Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, shared Thomas Ichim’s, President and Chief Scientific Officer at Immorta Bio, shared on X:
“Our ImmunityBio team is having great reception at World Conference Lung Cancer (WCLC26) in Seoul Korea discussing ReQ201A-NSCLC (Phase 3).
The world is waking up to the fact that ALC (absolute lymphocyte count) and Natural Killer (NK) cells matter to prolong life.The conclusion from the Chudzik abstract is consistent with what we saw in QUILT-3.055
Abstract: P3.175: Peripheral Blood Immunophenotyping Reveals Patterns of Short and Durable Immunotherapy Response in NSCLC. Robert Chudzik et al., 2026″
Other articles featuring Dr. Patrick on OncoDaily.